Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Involvement

NCT06449313 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer Stage III

Interventions

DRUG: Cemiplimab-Rwlc

Sponsor

Georgetown University

Collaborators

[object Object]